Related Experiment Videos
[Increased pre- and postoperative thrombocyte activity in vascular surgery patients]
C B Reininger1, A J Reininger, B Steckmeier
1Chirurgische Klinik Innenstadt der Ludwig-Maximilians-Universität München.
VASA. Zeitschrift Fur Gefasskrankheiten
|January 1, 1994
Summary
Vascular surgery significantly increases platelet reactivity and hypercoagulability in peripheral arterial disease (PAD) patients, despite aspirin and heparin therapy. This highlights the need for improved treatments and monitoring tools for platelet function.
Area of Science:
- Cardiovascular Science
- Hematology
- Surgical Research
Context:
- Peripheral arterial disease (PAD) patients undergoing vascular surgery exhibit altered platelet function.
- Preoperative and perioperative platelet behavior is crucial for surgical outcomes.
- Current antiplatelet and anticoagulant therapies may not fully mitigate surgical prothrombotic effects.
Purpose:
- To investigate the impact of vascular surgery on platelet function and reactivity in PAD patients.
- To evaluate platelet adhesion, aggregation, and count changes perioperatively.
- To assess the effectiveness of aspirin and heparin in managing surgical-induced hypercoagulability.
Summary:
- Vascular surgery significantly increases platelet reactivity (adhesivity and aggregability) and plasma fibrinogen in PAD patients, even with aspirin and heparin.
- Platelet count decreased, and thrombocytopenia occurred in 12 patients during unfractionated heparin (UH) administration.
- The Stagnation Point Adhesio-Aggregometer (SPAA) proved useful for continuous monitoring of platelet function.
- Hypercoagulability was observed despite standard perioperative anticoagulation and antiplatelet therapy.
Impact:
- Findings underscore the need for enhanced therapeutic strategies to manage perioperative hypercoagulability in PAD.
- The SPAA demonstrates potential as a valuable tool for monitoring platelet function and guiding treatment.
- Results suggest limitations in current prophylactic measures against thrombotic complications post-vascular surgery.